首页> 外文期刊>Drug Design, Development and Therapy >Arsenic sulfide, the main component of realgar, a?traditional Chinese medicine, induces apoptosis of?gastric cancer cells in vitro and in vivo
【24h】

Arsenic sulfide, the main component of realgar, a?traditional Chinese medicine, induces apoptosis of?gastric cancer cells in vitro and in vivo

机译:雄黄(传统中药)的主要成分硫化砷可在体内和体外诱导胃癌细胞的凋亡

获取原文
           

摘要

Background: Arsenic sulfide (As4S4), the main component of realgar, a traditional Chinese medicine, has shown antitumor efficacy in several tumor types, especially for acute promyelocytic leukemia. In this study, we aimed to explore the efficacy and mechanism of As4S4 in gastric cancer.Methods: The effect of As4S4 on cell proliferation and apoptosis of gastric cancer cells was investigated by MTT assay, 4',6-diamidino-2-phenylindole (DAPI) staining, and annexin V–fluorescein isothiocyanate/propidium iodide staining using gastric cancer cell lines AGS (harboring wild-type p53) and MGC803 (harboring mutant p53) in vitro. The expression of apoptosis-related proteins was measured by Western blotting, real-time polymerase chain reaction, and immunohistochemistry analysis. Mouse xenograft models were established by inoculation with MGC803 cells, and the morphology and the proportion of apoptotic cells in tumor tissues were detected by hematoxylin and eosin staining and TdT-mediated dUTP nick end labeling (TUNEL) assay, respectively. Results: As4S4 inhibited the proliferation and induced apoptosis of AGS and MGC803 cells in a time- and dose-dependent manner. As4S4 upregulated the expression of Bax and MDM2 while downregulated the expression of Bcl-2. The expression of p53 increased significantly in the AGS cells but did not readily increase in the MGC803 cells, which harbored mutant p53. Pifithrin-α, a p53 inhibitor, blocked the modulation of As4S4 on AGS cells, but not on MGC803 cells. Using xenograft as a model, we showed that As4S4 suppressed tumor growth and induced apoptosis in vivo and that the expression of p53 increased accordingly.Conclusion: As4S4 is a potent cytotoxic agent for gastric cancer cells, as it induced apoptosis both in vitro and in vivo through a p53-dependent pathway. Our data indicate that As4S4 may have therapeutic potential in gastric cancer.
机译:背景:作为传统中药雄黄的主要成分,硫化砷(As4S4)在几种肿瘤类型中均显示出抗肿瘤功效,尤其是对于急性早幼粒细胞白血病。方法:采用MTT法检测4',6-二mid基-2-苯基吲哚(4',6-二mid基-2-苯基吲哚),研究​​As4S4对胃癌细胞增殖和凋亡的影响。 DAPI)染色,并在体外使用胃癌细胞系AGS(携带野生型p53)和MGC803(携带突变p53)对Annexin V-异硫氰酸荧光素/碘化丙啶进行染色。通过蛋白质印迹,实时聚合酶链反应和免疫组化分析测量凋亡相关蛋白的表达。通过接种MGC803细胞建立小鼠异种移植模型,并分别通过苏木精和曙红染色和TdT介导的dUTP缺口末端标记(TUNEL)检测来检测肿瘤组织的形态和凋亡细胞比例。结果:As4S4以时间和剂量依赖性的方式抑制AGS和MGC803细胞的增殖并诱导其凋亡。 As4S4上调Bax和MDM2的表达,而下调Bcl-2的表达。 p53的表达在AGS细胞中显着增加,但在带有突变p53的MGC803细胞中却不容易增加。 pifithrin-α(一种p53抑制剂)阻断了AGS细胞上As4S4的调节,但未阻断MGC803细胞上的As4S4调节。以异种移植为模型,我们发现As4S4抑制了肿瘤的生长并诱导了其在体内的凋亡,并且p53的表达相应增加。结论:As4S4是一种有效的胃癌细胞杀伤剂,因为它在体内外均能诱导凋亡。通过p53依赖性途径。我们的数据表明As4S4在胃癌中可能具有治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号